Horst Olschewski
Overview
Explore the profile of Horst Olschewski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
265
Citations
9020
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yogeswaran A, Funderich M, Olschewski H, Kovacs G, Kiely D, Lawrie A, et al.
ERJ Open Res
. 2025 Feb;
11(1).
PMID: 40008170
Introduction: The definition of pulmonary hypertension (PH) was recently changed and led to a new subset of PH patients with mildly impaired pulmonary haemodynamics, characterised by a mean pulmonary artery...
2.
Zeder K, Sassmann T, Foris V, Douschan P, Olschewski H, Kovacs G
Int J Cardiol Congenit Heart Dis
. 2024 Dec;
17:100519.
PMID: 39711774
Severe pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD) is currently defined by an elevated mean pulmonary arterial pressure and strongly elevated pulmonary vascular resistance >5 wood units. Clinically,...
3.
Zeder K, Avian A, Olschewski H, Kovacs G
Eur Respir J
. 2024 Nov;
64(5).
PMID: 39609039
No abstract available.
4.
Kovacs G, Humbert M, Avian A, Lewis G, Ulrich S, Vonk Noordegraaf A, et al.
Eur Respir J
. 2024 Nov;
64(6).
PMID: 39603672
Background: Exercise pulmonary hypertension (PH) was defined by a mean pulmonary arterial pressure (mPAP)/cardiac output (CO) slope >3 mmHg·min·L between rest and exercise in the 2022 European Society of Cardiology/European...
5.
Hesse C, Kovacs G, Scheidl S, Olschewski H
SAGE Open Med Case Rep
. 2024 Nov;
12:2050313X241292529.
PMID: 39574498
Pulmonary veno-occlusive disease has a significantly worse prognosis than idiopathic pulmonary arterial hypertension. According to a case series from France, the median survival time from diagnosis to death or lung...
6.
John T, Avian A, John N, Eger A, Foris V, Zeder K, et al.
Chest
. 2024 Sep;
167(2):573-584.
PMID: 39341493
Background: Echocardiographic tricuspid annular plane systolic excursion (TAPSE) to systolic pulmonary arterial pressure (sPAP) ratio is a noninvasive surrogate for right ventricle (RV)-pulmonary arterial (PA) coupling. It has been related...
7.
Dardi F, Boucly A, Benza R, Frantz R, Mercurio V, Olschewski H, et al.
Eur Respir J
. 2024 Aug;
64(4).
PMID: 39209472
Risk stratification has gained an increasing role in predicting outcomes and guiding the treatment of patients with pulmonary arterial hypertension (PAH). The most predictive prognostic factors are three noninvasive parameters...
8.
Tello K, Yogeswaran A, Majeed R, Kiely D, Lawrie A, Brittain E, et al.
Chest
. 2024 Aug;
167(1):224-240.
PMID: 39182575
Background: Patients with COPD frequently demonstrate pulmonary hypertension (PH). Severe PH in patients with COPD, identified by pulmonary vascular resistance (PVR) of > 5 Wood units (WU), is closely linked...
9.
Kovacs G, Moutchia J, Zeder K, Maron B, Al-Naamani N, Ventetuolo C, et al.
Am J Respir Crit Care Med
. 2024 Jul;
210(6):844-847.
PMID: 38980192
No abstract available.
10.
Stoleriu M, Pienn M, Joerres R, Alter P, Fero T, Urschler M, et al.
Int J Chron Obstruct Pulmon Dis
. 2024 Jul;
19:1515-1529.
PMID: 38974817
Purpose: The aim of this study was to evaluate the association between computed tomography (CT) quantitative pulmonary vessel morphology and lung function, disease severity, and mortality risk in patients with...